The WHO said on Saturday that it has asked vaccine manufacturer Bharat Biotech to upgrade the facilities and rectify the deficiencies found in the inspection.
The World Health Organization (WHO) has banned the international supply of Covaxin, an anti-Covid-19 vaccine manufactured by Bharat Biotech. WHO says that this decision has been taken due to lack of Good Manufacturing Practices (GMP) i.e. good production practices. Giving this information, the WHO said on Saturday that it has stopped the supply through United Nations agencies of Covaxin, the COVID-19 vaccine manufactured by Bharat Biotech, and asked the manufacturer to upgrade the facilities and address the deficiencies found in the inspection. asked for.
Petrol-Diesel Price Hike: The process of increasing fuel prices is not stopping, prices increased for the 11th time in 13 days, check latest prices
WHO statement
According to the statement, the WHO has asked the countries receiving the vaccine to take appropriate action, although the WHO has not clarified what the appropriate action would be. The WHO says the vaccine is effective and there is no concern about safety, but stopping production for export would disrupt the supply of covaccine. The WHO has further said that this ban has been imposed after the results of the WHO Post Emergency Use Listing (EUL) inspection from March 14 to 22. WHO said that the company has decided to suspend its production for export as a precaution.
SEBI Order: Ban on new schemes of mutual funds till June, big decision of SEBI in the interest of investors
The statement issued by WHO said that the company is committed to address the shortcomings of GMP and is developing a corrective and preventive action plan to be submitted to the Drugs Controller General of India (DCGI) and WHO. At the same time, there is no response from Bharat Biotech on this yet. A day earlier, it was said on behalf of Bharat Biotech that the company is going to reduce the production of anti-corona vaccine vaccine for some time. Bharat Biotech had said that it is temporarily reducing the production of the COVID vaccine in all manufacturing units.
,